3r4l

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:3r4l.jpg|left|200px]]
+
[[Image:3r4l.png|left|200px]]
-
<!--
 
-
The line below this paragraph, containing "STRUCTURE_3r4l", creates the "Structure Box" on the page.
 
-
You may change the PDB parameter (which sets the PDB file loaded into the applet)
 
-
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
 
-
or leave the SCENE parameter empty for the default display.
 
-
-->
 
{{STRUCTURE_3r4l| PDB=3r4l | SCENE= }}
{{STRUCTURE_3r4l| PDB=3r4l | SCENE= }}
===Human very long half life Plasminogen Activator Inhibitor type-1===
===Human very long half life Plasminogen Activator Inhibitor type-1===
- 
-
<!--
 
-
The line below this paragraph, {{ABSTRACT_PUBMED_21947232}}, adds the Publication Abstract to the page
 
-
(as it appears on PubMed at http://www.pubmed.gov), where 21947232 is the PubMed ID number.
 
-
-->
 
{{ABSTRACT_PUBMED_21947232}}
{{ABSTRACT_PUBMED_21947232}}
==About this Structure==
==About this Structure==
-
[[3r4l]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3R4L OCA].
+
[[3r4l]] is a 1 chain structure of [[Plasminogen activator inhibitor]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3R4L OCA].
 +
 
 +
==See Also==
 +
*[[Plasminogen activator inhibitor|Plasminogen activator inhibitor]]
==Reference==
==Reference==

Revision as of 18:36, 25 July 2012

Template:STRUCTURE 3r4l

Contents

Human very long half life Plasminogen Activator Inhibitor type-1

Template:ABSTRACT PUBMED 21947232

About this Structure

3r4l is a 1 chain structure of Plasminogen activator inhibitor with sequence from Homo sapiens. Full crystallographic information is available from OCA.

See Also

Reference

  • Jankun J, Yang J, Zheng H, Han FQ, Al-Senaidy A, Skrzypczak-Jankun E. Remarkable extension of PAI-1 half-life surprisingly brings no changes to its structure. Int J Mol Med. 2012 Jan;29(1):61-4. doi: 10.3892/ijmm.2011.798. Epub 2011, Sep 22. PMID:21947232 doi:10.3892/ijmm.2011.798
  • Chorostowska-Wynimko J, Swiercz R, Skrzypczak-Jankun E, Wojtowicz A, Selman SH, Jankun J. A novel form of the plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to cancer and angiogenesis. Mol Cancer Ther. 2003 Jan;2(1):19-28. PMID:12533669
  • . PMID:019082507

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools